Democracy Now! (10/19/17)
This week, President Donald Trump’s nominee for drug czar, Republican Congressmember Tom Marino, had to withdraw from consideration after a Washington Post/”60 Minutes investigation found he led a drug industry-backed effort to pass a law that weakened the U.S. Drug Enforcement Administration’s ability to crack down on addictive opioids.
Meanwhile, calls are growing to look at the major pharmaceutical companies that have fueled the opioid crisis. A new investigation by Esquire magazine reveals how the secretive Sackler family, owners of the company that invented OxyContin, downplayed the risks of addiction and exploited doctors’ confusion over the drug’s strength. We speak with Christopher Glazek, the Esquire reporter behind the story.
(Commoner Call cartoon by Mark L. Taylor, 2017. Open source and free to use with link to www.thecommonercall.org )
Explosive Esquire Article: The Secretive Family Making Billions Off America’s Opioid Addiction Crisis
By Christopher Glazek
You’re aware America is under siege, fighting an opioid crisis that has exploded into a public-health emergency. You’ve heard of OxyContin, the pain medication to which countless patients have become addicted. But do you know that the company that makes Oxy and reaps the billions of dollars in profits it generates is owned by one family?… Read the Rest
Govt. Enabled Corporate Drug Dealers: Profiting Off Too Many Pills
The callous betrayal of the public portrayed in this story is absolutely shocking.
The Center for Investigative Reporting (10/21/17)
Drug overdoses now are the leading cause of death among Americans under 50, largely thanks to a surge in opioid use. Although heroin and fentanyl have dominated the headlines in recent years, the problem started with a flood of prescription painkillers, distributed by some of the country’s biggest corporations.
At the urging of his editor, Washington Post reporter Lenny Bernstein set out to learn why millions of pills were being sent to cities and towns across the U.S. – and why distributors seemed to shrug off evidence of rampant abuse. His reporting took him to Washington’s halls of power: the Department of Justice, Capitol Hill and deep inside the Drug Enforcement Administration, with a senior official who saw the crisis coming.
- Read: The Drug Industry’s Triumph Over the DEA
- Watch: Ex-DEA agent: Opioid crisis fueled by drug industry and Congress